GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028

Description

MARKET OUTLOOK

CRI’s report puts forth that the global clinical trials support services market would register growth at a CAGR of 7.84% during the forecast phase of 2022-2028.
The rise in the incidence of diseases has majorly increased the demand for clinical trials support services, which is expected to drive the market growth. Further, the efficiency of support services in overcoming the barriers encountered while conducting clinical trials is another key factor supporting growth.
On the other hand, the delays in receiving regulatory approval for carrying out clinical trials due to stringent regulations are hindering the growth process. Moreover, the disadvantages associated with the use of open-source software are also negatively impacting market progress.
However, the increasing demand for pharmaceuticals & vaccines, along with the growing number of strategic acquisitions by market players, are expected to open up new growth opportunities for the clinical trial support services market.

REGIONAL OUTLOOK

The global market for clinical trials support services encompasses North America, Europe, the Asia-Pacific, Latin America, and the Middle East and Africa.
North America is the leading region in the global market, and held the largest market share in 2021. Most key players in the clinical trials support services market, such as IQVIA, Parexel, and Charles River Laboratories, among others, are based in the United States. This largely benefits the North American market.
Whereas, the high population of the Asia-Pacific, especially Asia, adds an advantage to the market in this region. This is because researchers gain access to a large number of potential trial participants. The Asia-Pacific is expected to witness the fastest growth in the global market over the considered period.

COMPETITIVE OUTLOOK

The leading players profiled in the global clinical trials support services market report include Charles River Laboratories, Advanced Clinical, WuXi AppTec, Parexel, IQVIA, Clinipace, PSI CRO, Worldwide Clinical Trials, Labcorp Drug Development, KCR, ICON Plc, Alcura, Medpace, CTI Clinical Trial and Consulting Services Inc, and Syneos Health.
Worldwide Clinical Trials is a globally leading contract research organization (CRO) that is invested in various therapeutic areas, such as cardiovascular, oncology, neuroscience, metabolic, and rare disease.
It offers several services, such as early phase/phase I development, phase II b-III clinical trials, phase III b- phase IV clinical trials, etc. Biostatistics services offered by the organization comprise statistical analysis plan development, sample size estimation & methodology review, rapid reporting, and data delivery. Founded in 1986, Worldwide Clinical Trials has a business presence in North America, Asia-Pacific, Latin America, and Europe.

TABLE OF CONTENTS

1. GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET – SUMMARY
2. INDUSTRY OUTLOOK
2.1. IMPACT OF COVID-19 ON THE CLINICAL TRIALS SUPPORT SERVICES MARKET
2.2. KEY INSIGHTS
2.2.1. KEY PLAYERS’ PROMISING COLLABORATIONS
2.2.2. INCREASE IN SCREENING TESTS
2.3. PORTER’S FIVE FORCES ANALYSIS
2.3.1. THREAT OF NEW ENTRANTS
2.3.2. THREAT OF SUBSTITUTES
2.3.3. BARGAINING POWER OF BUYERS
2.3.4. BARGAINING POWER OF SUPPLIERS
2.3.5. THREAT OF COMPETITIVE RIVALRY
2.4. KEY BUYING IMPACT ANALYSIS
2.4.1. PERFORMANCE
2.4.2. EASE OF USE
2.4.3. SECURITY
2.4.4. COST EFFECTIVENESS
2.5. MARKET ATTRACTIVENESS INDEX
2.6. VENDOR SCORECARD
2.7. INDUSTRY COMPONENTS
2.8. REGULATORY FRAMEWORK
2.9. KEY MARKET STRATEGIES
2.9.1. ACQUISITIONS
2.9.2. PRODUCT LAUNCHES
2.9.3. CONTRACTS & AGREEMENTS
2.9.4. INVESTMENTS & EXPANSIONS
2.10. MARKET DRIVERS
2.10.1. NEED TO OVERCOME THE BARRIERS IN CLINICAL TRIALS
2.10.2. RISE IN TRIALS DUE TO INCREASED DISEASE INCIDENCE
2.11. MARKET CHALLENGES
2.11.1. DELAYED APPROVAL DUE TO STRINGENT REGULATORY FRAMEWORK
2.11.2. USE OF OPEN-SOURCE SOFTWARE
2.12. MARKET OPPORTUNITIES
2.12.1. INCREASING DEMAND FOR VACCINES AND PHARMACEUTICALS
2.12.2. DATA MANAGEMENT SERVICE EXPECTED TO WITNESS NOTABLE GROWTH
2.12.3. ACQUISITIONS IN THE CLINICAL TRIALS SUPPORT SERVICES MARKET
3. GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET OUTLOOK – BY PHASE TYPE
3.1. PHASE I
3.2. PHASE II
3.3. PHASE III
3.4. PHASE IV
4. GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET OUTLOOK – BY SERVICE
4.1. CLINICAL TRIAL SITE MANAGEMENT
4.2. ADMINISTRATIVE SERVICES
4.3. PATIENT RECRUITMENT MANAGEMENT
4.4. REGULATORY SERVICES
4.5. DATA MANAGEMENT
4.6. OTHER SERVICES
5. GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET OUTLOOK – BY SPONSOR
5.1. PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
5.2. MEDICAL DEVICE COMPANIES
5.3. OTHER SPONSORS
6. GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET – REGIONAL OUTLOOK
6.1. NORTH AMERICA
6.1.1. MARKET OUTLOOK BY SERVICE
6.1.2. MARKET OUTLOOK BY PHASE TYPE
6.1.3. MARKET OUTLOOK BY SPONSOR
6.1.4. COUNTRY ANALYSIS
6.1.4.1. UNITED STATES
6.1.4.2. CANADA
6.2. EUROPE
6.2.1. MARKET OUTLOOK BY SERVICE
6.2.2. MARKET OUTLOOK BY PHASE TYPE
6.2.3. MARKET OUTLOOK BY SPONSOR
6.2.4. COUNTRY ANALYSIS
6.2.4.1. UNITED KINGDOM
6.2.4.2. GERMANY
6.2.4.3. FRANCE
6.2.4.4. SPAIN
6.2.4.5. ITALY
6.2.4.6. REST OF EUROPE
6.3. ASIA-PACIFIC
6.3.1. MARKET OUTLOOK BY SERVICE
6.3.2. MARKET OUTLOOK BY PHASE TYPE
6.3.3. MARKET OUTLOOK BY SPONSOR
6.3.4. COUNTRY ANALYSIS
6.3.4.1. CHINA
6.3.4.2. JAPAN
6.3.4.3. INDIA
6.3.4.4. SOUTH KOREA
6.3.4.5. ASEAN COUNTRIES
6.3.4.6. AUSTRALIA & NEW ZEALAND
6.3.4.7. REST OF ASIA-PACIFIC
6.4. LATIN AMERICA
6.4.1. MARKET OUTLOOK BY SERVICE
6.4.2. MARKET OUTLOOK BY PHASE TYPE
6.4.3. MARKET OUTLOOK BY SPONSOR
6.4.4. COUNTRY ANALYSIS
6.4.4.1. BRAZIL
6.4.4.2. MEXICO
6.4.4.3. REST OF LATIN AMERICA
6.5. MIDDLE EAST AND AFRICA
6.5.1. MARKET OUTLOOK BY SERVICE
6.5.2. MARKET OUTLOOK BY PHASE TYPE
6.5.3. MARKET OUTLOOK BY SPONSOR
6.5.4. COUNTRY ANALYSIS
6.5.4.1. UNITED ARAB EMIRATES
6.5.4.2. SAUDI ARABIA
6.5.4.3. TURKEY
6.5.4.4. SOUTH AFRICA
6.5.4.5. REST OF MIDDLE EAST & AFRICA
7. COMPETITIVE LANDSCAPE
7.1. IQVIA
7.2. PAREXEL
7.3. ICON PLC
7.4. SYNEOS HEALTH
7.5. LABCORP DRUG DEVELOPMENT
7.6. CLINIPACE
7.7. KCR
7.8. CHARLES RIVER LABORATORIES
7.9. MEDPACE
7.10. ALCURA
7.11. PSI CRO
7.12. WORLDWIDE CLINICAL TRIALS
7.13. CTI CLINICAL TRIAL AND CONSULTING SERVICES INC
7.14. WUXI APPTEC
7.15. ADVANCED CLINICAL
8. RESEARCH METHODOLOGY & SCOPE
8.1. RESEARCH SCOPE & DELIVERABLES
8.2. SOURCES OF DATA
8.3. RESEARCH METHODOLOGY

TABLE LIST

TABLE 1: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, REGIONAL OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 2: LIST OF COLLABORATIONS
TABLE 3: VENDOR SCORECARD
TABLE 4: REGULATORY FRAMEWORK
TABLE 5: LIST OF ACQUISITIONS
TABLE 6: LIST OF PRODUCT LAUNCHES
TABLE 7: LIST OF CONTRACTS & AGREEMENTS
TABLE 8: LIST OF INVESTMENTS & BUSINESS EXPANSIONS
TABLE 9: LIST OF PANDEMIC OUTBREAKS
TABLE 10: LIST OF OPEN-SOURCE SOFTWARE
TABLE 11: LAUNCH OF MEDICAL DRUGS
TABLE 12: PROMISING ACQUISITIONS IN THE MARKET
TABLE 13: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE TYPE, 2022-2028 (IN $ MILLION)
TABLE 14: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, 2022-2028 (IN $ MILLION)
TABLE 15: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, 2022-2028 (IN $ MILLION)
TABLE 16: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, REGIONAL OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 17: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, 2022-2028 (IN $ MILLION)
TABLE 18: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE TYPE, 2022-2028 (IN $ MILLION)
TABLE 19: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, 2022-2028 (IN $ MILLION)
TABLE 20: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 21: NUMBER AND TYPES OF REGISTERED STUDIES
TABLE 22: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, 2022-2028 (IN $ MILLION)
TABLE 23: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE TYPE, 2022-2028 (IN $ MILLION)
TABLE 24: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, 2022-2028 (IN $ MILLION)
TABLE 25: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 26: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, 2022-2028 (IN $ MILLION)
TABLE 27: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE TYPE, 2022-2028 (IN $ MILLION)
TABLE 28: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, 2022-2028 (IN $ MILLION)
TABLE 29: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 30: LATIN AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, 2022-2028 (IN $ MILLION)
TABLE 31: LATIN AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE TYPE, 2022-2028 (IN $ MILLION)
TABLE 32: LATIN AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, 2022-2028 (IN $ MILLION)
TABLE 33: LATIN AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 34: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, 2022-2028 (IN $ MILLION)
TABLE 35: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE TYPE, 2022-2028 (IN $ MILLION)
TABLE 36: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, 2022-2028 (IN $ MILLION)
TABLE 37: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)

FIGURE LIST

FIGURE 1: KEY BUYING IMPACT ANALYSIS
FIGURE 2: MARKET ATTRACTIVENESS INDEX
FIGURE 3: INDUSTRY COMPONENTS
FIGURE 4: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE TYPE, 2021 & 2028 (IN %)
FIGURE 5: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE I, 2022-2028 (IN $ MILLION)
FIGURE 6: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE II, 2022-2028 (IN $ MILLION)
FIGURE 7: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE III, 2022-2028 (IN $ MILLION)
FIGURE 8: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE IV, 2022-2028 (IN $ MILLION)
FIGURE 9: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, 2021 & 2028 (IN %)
FIGURE 10: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY CLINICAL TRIAL SITE MANAGEMENT, 2022-2028 (IN $ MILLION)
FIGURE 11: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY ADMINISTRATIVE SERVICES, 2022-2028 (IN $ MILLION)
FIGURE 12: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT RECRUITMENT MANAGEMENT, 2022-2028 (IN $ MILLION)
FIGURE 13: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY REGULATORY SERVICES, 2022-2028 (IN $ MILLION)
FIGURE 14: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY DATA MANAGEMENT, 2022-2028 (IN $ MILLION)
FIGURE 15: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY OTHER SERVICES, 2022-2028 (IN $ MILLION)
FIGURE 16: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, 2021 & 2028 (IN %)
FIGURE 17: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, 2022-2028 (IN $ MILLION)
FIGURE 18: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY MEDICAL DEVICE COMPANIES, 2022-2028 (IN $ MILLION)
FIGURE 19: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY OTHER SPONSORS, 2022-2028 (IN $ MILLION)
FIGURE 20: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, REGIONAL OUTLOOK, 2021 & 2028 (IN %)
FIGURE 21: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE 22: UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 23: CANADA CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 24: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE 25: UNITED KINGDOM CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 26: GERMANY CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 27: FRANCE CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 28: SPAIN CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 29: ITALY CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 30: REST OF EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 31: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE 32: CHINA CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 33: JAPAN CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 34: INDIA CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 35: SOUTH KOREA CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 36: ASEAN COUNTRIES CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 37: AUSTRALIA & NEW ZEALAND CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 38: REST OF ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 39: LATIN AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE 40: BRAZIL CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 41: MEXICO CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 42: REST OF LATIN AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 43: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE 44: UNITED ARAB EMIRATES CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 45: SAUDI ARABIA CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 46: TURKEY CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 47: SOUTH AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 48: REST OF MIDDLE EAST & AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)